Research Analyst at Jefferies Financial Group Inc.
No comprehensive professional profile for a Phebe, Phoebe, or similar analyst at Jefferies was found through available search results. No LinkedIn profile, job titles, coverage sectors, or performance credentials could be identified for a Jefferies analyst by this name. Without verifiable data, there is no record of a Phebe serving as an equity research analyst or holding another analyst role at Jefferies with coverage of public companies, performance track record, or recognized financial credentials.
Asked about the target patient population for the uveitis trial (refractory vs. not), its potential for an orphan indication designation, and the feasibility of orphan pricing given existing competition from HUMIRA.
The uveitis trial includes patients with active disease, some of whom have prior biologic exposure. The company sees a high unmet need and an opportunity to expand the market but stated it is too early to comment on specific pricing strategies.
Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.
Trusted by leading investment firms and analysts